ATA905384A - Verfahren zur herstellung analgetischer und anti-inflammatorischer mittel - Google Patents

Verfahren zur herstellung analgetischer und anti-inflammatorischer mittel

Info

Publication number
ATA905384A
ATA905384A AT0905384A AT905384A ATA905384A AT A905384 A ATA905384 A AT A905384A AT 0905384 A AT0905384 A AT 0905384A AT 905384 A AT905384 A AT 905384A AT A905384 A ATA905384 A AT A905384A
Authority
AT
Austria
Prior art keywords
inflammative
analgetic
agents
producing
producing analgetic
Prior art date
Application number
AT0905384A
Other languages
English (en)
Other versions
AT389997B (de
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of ATA905384A publication Critical patent/ATA905384A/de
Application granted granted Critical
Publication of AT389997B publication Critical patent/AT389997B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
AT0905384A 1983-12-12 1984-12-12 Verfahren zur herstellung analgetischer und anti-inflammatorischer mittel AT389997B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/560,576 US4558051A (en) 1983-10-11 1983-12-12 Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same

Publications (2)

Publication Number Publication Date
ATA905384A true ATA905384A (de) 1989-08-15
AT389997B AT389997B (de) 1990-02-26

Family

ID=24238396

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0905384A AT389997B (de) 1983-12-12 1984-12-12 Verfahren zur herstellung analgetischer und anti-inflammatorischer mittel

Country Status (15)

Country Link
US (1) US4558051A (de)
EP (1) EP0165308B1 (de)
JP (1) JPS61500665A (de)
AT (1) AT389997B (de)
AU (1) AU574419B2 (de)
CA (1) CA1246453A (de)
CH (1) CH669730A5 (de)
DE (1) DE3490583T1 (de)
GB (1) GB2161076B (de)
IE (1) IE58158B1 (de)
IT (1) IT1177389B (de)
NL (1) NL8420316A (de)
SE (1) SE469874B (de)
WO (1) WO1985002540A1 (de)
ZA (1) ZA849675B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
HU197746B (en) * 1985-09-05 1989-05-29 Sandoz Ag Process for producing xantin derivatives and pharmaceutical compositions containing them
CH669523A5 (de) * 1986-06-25 1989-03-31 Mepha Ag
DE3779374D1 (en) * 1986-08-28 1992-07-02 Sandoz Ag Xanthinderivate.
CH670090A5 (de) * 1986-10-27 1989-05-12 Nestle Sa
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196429A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196430A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4859704A (en) * 1987-10-15 1989-08-22 Oratech Pharmaceutical Development Corporation Water soluble ibuprofen compositions and methods of making them
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
EP0317206B1 (de) * 1987-11-13 1993-04-28 Glaxo Group Limited Phenethanolamin-Derivate
US4883818A (en) * 1987-11-17 1989-11-28 Analgesic Associates Onset-hastened/enhanced analgesia
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
JP2843634B2 (ja) * 1989-03-06 1999-01-06 協和醗酵工業株式会社 キサンチン誘導体
GB8906792D0 (en) * 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
WO1992004021A1 (en) * 1990-09-11 1992-03-19 Richardson Vicks Inc. Method for providing improved analgesic effect
EP0663819A4 (de) * 1992-09-29 1998-05-27 Merck & Co Inc Ibuprofen-coffein-kombinationen.
US5340813A (en) * 1992-11-09 1994-08-23 Cell Therapeutics, Inc. Substituted aminoalkyl xanthine compounds
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
WO1994025462A1 (en) * 1993-05-03 1994-11-10 The United States Of America, Represented By The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US6586429B2 (en) * 2000-11-29 2003-07-01 Cell Therapeutics, Inc. Tricyclic fused xanthine compounds and their uses
WO2003004033A1 (en) 2001-07-06 2003-01-16 Penwest Pharmaceuticals Company Sustained release formulations of oxymorphone
EP1404333A1 (de) 2001-07-06 2004-04-07 Endo Pharmaceuticals Inc. Kontrolliert freisetzende formulierungen von oxymorphon
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
ATE520694T1 (de) 2001-11-09 2011-09-15 Gilead Palo Alto Inc A2b-adenosinrezeptorantagonisten
US7125993B2 (en) * 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US20080318983A1 (en) * 2001-11-09 2008-12-25 Rao Kalla A2b adenosine receptor antagonists
US6977300B2 (en) * 2001-11-09 2005-12-20 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US7317017B2 (en) * 2002-11-08 2008-01-08 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
SI1789053T1 (sl) * 2004-09-01 2012-09-28 Gilead Sciences Inc Postopek celjenja rane z uporabo antagonistov A2B adenozinskih receptorjev
CL2007002425A1 (es) * 2006-08-22 2008-06-27 Albermarle Corp Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.
EP3280417B1 (de) 2015-04-08 2020-07-29 Lewis and Clark Pharmaceuticals, Inc. Xanthin-substituierte alkynylcarbamate/reverse carbamate als a2b-antagonisten
CN109912598B (zh) * 2019-03-27 2022-09-13 四川大学华西医院 防治炎症反应的核苷类衍生物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US3936528A (en) * 1974-02-13 1976-02-03 Syntex Corporation Analgesic formulations having enhanced therapeutic activity
AU532600B2 (en) * 1977-04-02 1983-10-06 Hoechst A.G. Alkenyl xanthines and pharmaceutical compositions
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
ZA835324B (en) * 1982-07-22 1984-09-26 Abraham Sunshine Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
US4479956A (en) * 1983-04-26 1984-10-30 Analgeic Associates Analgesic compositions comprising propiram and methods of using same

Also Published As

Publication number Publication date
AT389997B (de) 1990-02-26
JPS61500665A (ja) 1986-04-10
CH669730A5 (de) 1989-04-14
AU3747485A (en) 1985-06-26
GB2161076B (en) 1988-03-30
ZA849675B (en) 1985-07-31
CA1246453A (en) 1988-12-13
WO1985002540A1 (en) 1985-06-20
NL8420316A (nl) 1985-11-01
AU574419B2 (en) 1988-07-07
SE8503762L (sv) 1985-08-09
SE8503762D0 (sv) 1985-08-09
GB8519256D0 (en) 1985-09-04
US4558051A (en) 1985-12-10
IT8424009A0 (it) 1984-12-12
DE3490583T1 (de) 1986-04-03
IE58158B1 (en) 1993-07-28
GB2161076A (en) 1986-01-08
EP0165308A1 (de) 1985-12-27
IT1177389B (it) 1987-08-26
EP0165308A4 (de) 1986-05-16
IE843166L (en) 1985-06-12
SE469874B (sv) 1993-10-04
IT8424009A1 (it) 1986-06-12
EP0165308B1 (de) 1989-03-22

Similar Documents

Publication Publication Date Title
ATA905384A (de) Verfahren zur herstellung analgetischer und anti-inflammatorischer mittel
DE3574827D1 (de) Verfahren zur herstellung von sekundaeren und primaeren aminen.
ATA910981A (de) Verfahren zur herstellung kosmetischer und therapeutischer zusammensetzungen
AT383808B (de) Verfahren zur herstellung von penemen
DE3481317D1 (de) Festschmiermittel und verfahren zur herstellung.
DE3686444D1 (de) N-fluorpyridiniumsalz und verfahren zur herstellung.
DE3770176D1 (de) Verfahren zur herstellung von modellierten und geformten filtern.
DE69028917D1 (de) Antischwitzzusatzmittel und verfahren zur herstellung
ATA337285A (de) Verfahren zur herstellung von isosilybinfreiem silibinin
DE69321848D1 (de) Verfahren zur herstellung von 1,1,1,2,3,3-hexafluorpropan und von tetrafluorchlorpropen
DE3684511D1 (de) Verfahren zur herstellung von l-threonin und l-isoleucin.
DE3684922D1 (de) Verfahren zur herstellung von 2-phenylbenzotriazolen und 2-phenylbenzotriazol-n-oxyden.
DE3684632D1 (de) Tonerzusammensetzung und verfahren zur herstellung.
DE3581008D1 (de) Verfahren und einrichtung zur herstellung von stranggussbrammen.
DE3783480D1 (de) Verfahren und vorrichtung zur herstellung von schieberkernen.
ATA199684A (de) Verfahren zur herstellung von 6-deoxyanthracyclinonen
DE3584026D1 (de) Collagenase und verfahren zur herstellung derselben.
DE3765855D1 (de) Dimethylphenylsilylmethylpolysilan und verfahren zur herstellung desselben.
DE59502926D1 (de) Verfahren zur herstellung von alkaliaminoborhydriden und alkaliaminoborhydrid-komplexen
AT388293B (de) Stabiles, zahnbelag verhinderndes zahnpflegemittel und verfahren zur herstellung desselben
DE3574974D1 (de) Verfahren zur herstellung von milbemycinderivaten und einige in diesem verfahren verwendete derivate.
AT372067B (de) Verfahren zur herstellung von duenger und nuetzlichen nebenprodukten
ATA254688A (de) Verfahren zur herstellung analgetischer und antiinflammatorischer mittel
ATA247687A (de) Verfahren zur herstellung von 5-aryliden- und -alkylidensubstituierten hydantoinen
DE3883394D1 (de) Verfahren zur herstellung von dialkyltellur und dialkylselen.

Legal Events

Date Code Title Description
ELA Expired due to lapse of time